4. Standardized practice evolution: We agree that the benefits associated with standardizing care can be difficult to achieve. 4 The sharing and benchmarking 5 of data and the reporting solutions that are part of larger programs have provided powerful tools for encouraging the adoption of standard best practices and measuring the impact of these changes on critical care outcomes. 6 We also agree that studies using the best available analytics tools to make meaningful comparisons of alternative ICU telemedicine approaches and practices are important.
A Patient-Based Analysis of the Geographic Distribution of Mycobacterium avium complex, Mycobacterium abscessus, and
Mycobacterium kansasii Infections in the United States
To the Editor:
Nontuberculous mycobacteria (NTM) are ubiquitous and prevalent in the environment. 1 The prevalence of NTM among the elderly is 47 patients per 100,000 people. 2, 3 There is a lack of information on NTM species distribution on a state-by-state level in the United States.
journal.publications.chestnet.org Here, we present data on the geographic distribution of pulmonary Mycobacterium avium complex (MAC), Mycobacterium abscessus, and Mycobacterium kansasii infections in the United States.
We conducted a patient-centered, cross-sectional study via online survey that was distributed to patients who had received a diagnosis of pulmonary NTM. All data were collected between January and March 2016, using the NTM Info & Research, Inc. website (NTMinfo.org).
Heat map figures were generated to provide data on the density of distribution for the most commonly reported NTM isolates across the various states. The data grid was based on the geographic coordinates of each subject's city of residence and was generated by the Kriging method and available US mainland data.
Five hundred and thirty-seven subjects from 46 US states responded to the survey. The mean age was 66.9 years (range, 13 to 91 years), and 95% of the study participants were female. Previous treatment for NTM was reported in 259 (48%), active anti-NTM therapy in 139 (26%), and no treatment in 139 (26%). Five states had the highest number of respondents (n ¼ 268, or 50%), including the following: Florida, 85 (15.8%); California, 61 (11.3%); New York, 52 (9.7%); Texas, 36 (6.7%); and Pennsylvania, 34 (6.3%).
All respondents reported their isolated Mycobacterium species. Seven hundred and twenty-eight isolates were reported as some subjects reported being infected with more than one species. Table 1 shows the data of NTM-infected subjects and their mycobacterial species by state. Figures 1 and 2 show the distribution of MAC-and M abscessus-infected subjects at the state level.
Limited studies previously described the distribution of MAC, M abscessus, and M kansasii infection in individual states in the United States. We present new data mapping self-reported NTM infections confirming the coastal predominance of NTM. The higher frequency of NTM infection in these areas supports journal.publications.chestnet.org observations that very high numbers of NTM are present in coastal swamps 4 and estuaries. 5 This observed difference may be due to environmental factors such as water characteristics and geochemical differences in soil composition.
These data will help to improve the detection of NTM disease in the United States and enhance our knowledge of disease patterns. Detecting the geographic cluster of pathogenic NTM strains in the United States will help us to improve our preventive measures for those with underlying pulmonary disorders such as bronchiectasis.
